Skip to main content
. 2022 Jan 27;23(3):1492. doi: 10.3390/ijms23031492

Figure 5.

Figure 5

Enzyme protection assay of pCMV–Luc DNA containing nanocomplexes. Lane 1: positive control (untreated pDNA). Lane 2: negative control (pDNA + 10% FBS). Lanes 3–5: PLL–SeNP nanocomplexes with pDNA (w/w) (1:2.2; 1:2.7; 1:3.2). Lanes 6–8: LA–PLL–SeNP nanocomplexes with pDNA (w/w) (1:10.9; 1:14; 1:16.4).